Ascentage Pharma Group International is an investment holding company primarily engaged in the discovery, development, and commercialization of therapies for hematologic malignancies. The Company's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The Company's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), and multiple myeloma (MM). The Company primarily conducts its businesses in domestic market.
公司代碼AAPG
公司Ascentage Pharma Group International
CEOYang (Dajun)
網址https://www.ascentage.cn/
常見問題
Ascentage Pharma Group International(AAPG)的當前股價是多少?
Ascentage Pharma Group International(AAPG)的當前股價是 26.980。
Ascentage Pharma Group International 的股票代碼是什麼?
Ascentage Pharma Group International的股票代碼是AAPG。
Ascentage Pharma Group International股票的52週最高點是多少?
Ascentage Pharma Group International股票的52週最高點是48.450。
Ascentage Pharma Group International股票的52週最低點是多少?
Ascentage Pharma Group International股票的52週最低點是16.500。
Ascentage Pharma Group International的市值是多少?
Ascentage Pharma Group International的市值是--。
Ascentage Pharma Group International的淨利潤是多少?
Ascentage Pharma Group International的淨利潤為--。
現在Ascentage Pharma Group International(AAPG)的股票是買入、持有還是賣出?
根據分析師評級,Ascentage Pharma Group International(AAPG)的總體評級為--,目標價格為--。
Ascentage Pharma Group International(AAPG)股票的每股收益(EPS TTM)是多少
Ascentage Pharma Group International(AAPG)股票的每股收益(EPS TTM)是--。